Cagrilintide 5mg + Semaglutide 5mg
Two-compound lyophilized research blend combining cagrilintide, a long-acting amylin-receptor agonist analog, with semaglutide, a GLP-1 receptor agonist peptide. Laboratory research examines concurrent amylin-receptor (calcitonin / amylin family) and glucagon-like peptide-1 (GLP-1) receptor binding and downstream signaling in cellular and preclinical model systems. Each vial is supplied as lyophilized powder for reconstitution in qualified laboratory settings.
For Research Use Only. Not for human consumption. Intended strictly for laboratory and in-vitro research by qualified professionals. Not a drug, dietary supplement, or cosmetic. Not intended to diagnose, treat, cure, or prevent any disease. This product has not been evaluated by the U.S. Food and Drug Administration.
Veritas Coastal Labs supplies this Cagrilintide and Semaglutide blend for laboratory research use only. Batch documentation is posted at https://veritascoastallabs.com/coa/. Not for human consumption.
